0000886163-23-000057.txt : 20230925
0000886163-23-000057.hdr.sgml : 20230925
20230925164443
ACCESSION NUMBER: 0000886163-23-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230922
FILED AS OF DATE: 20230925
DATE AS OF CHANGE: 20230925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Todd C
CENTRAL INDEX KEY: 0001392029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 231276294
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-09-22
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001392029
Davis Todd C
3911 SORRENTO VALLEY, SUITE 110
SAN DIEGO
CA
92121
1
1
0
0
CHIEF EXECUTIVE OFFICER
0
Common Stock
2023-09-22
4
P
0
4000
59.3822
A
73090
D
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $58.975 to $59.930. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
By: /s/ Andrew Reardon For: Todd C. Davis
2023-09-25